Metavention

Focus
Procedure
Clinical Studies
Company

Homepage
Focus
Procedure
Clinical Studies
Company
Contact Us

Metavention Completes U.S. Enrollment in Groundbreaking Feasibility Study to Treat Type 2 Diabetes

Jan 31, 2022

Metavention Completes U.S. Enrollment in Groundbreaking Feasibility Study to Treat Type 2 Diabetes

Focus
Procedure
Clinical Studies
Company
News
Contact Us

Privacy Policy
Terms of Use
Cookie Policy
Sources

CAUTION: The iRF Denervation System is not approved for sale in any region and is limited by Federal (US) Law to investigational use only.

© 2024 Metavention. All Rights Reserved. Doc No. 1734 Rev 13 Jan 2024